ANNE WOJCICKI CEO AND CO-FOUNDER, 23ANDMe Anne co-founded 23andMe in 2006 after a decade spent in healthcare investing, focused primarily on biotechnology companies. Her hope was to empower consumers with access to their own genetic information and to create a way to...
JANET WOODCOCK M.D., DIRECTOR, CENTER FOR DRUG EVALUATION & RESEARCH, FDA Janet Woodcock is the director of the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration (FDA). Dr. Woodcock has shown dedication to personalized medicine by...
KRISHNA YESHWANT M.D., GENERAL PARTNER, GOOGLE VENTURES Dr. Krishna Yeshwant is a physician, programmer, and entrepreneur who has been working with Google Ventures since its inception. He first joined Google as part of the New Business Development team. Prior to...
PETER PAUL YU M.D., FACP, FASCO, DIRECTOR OF CANCER RESEARCH AT PALO ALTO MEDICAL FOUNDATION Dr. Peter Yu is a medical oncologist and expert in the area of digital health, especially oncology data representation and architecture. He is Immediate-Past President of the...
JENNIFER FONSTAD FOUNDING PARTNER, ASPECT VENTURES Jennifer is a respected mobile and software investor with special interests in Enterprise and Mobile Applications, Application Services, and Healthcare IT. She serves as Chairman of the Board of Flurry, and on several...
PMWC is the most comprehensive precision medicine conference. To receive the lastest news and updates from the field, subscribe to the newsletter here.
View the top 3 talks from PMWC here (password: top-videos).
